Maurizio Sessa (M Sessa)

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 40

Top Topics

Machine Learning

Lower Urinary Tract Symptoms

Mild Cognitive Impairment

Top Venues

Expert opinion on drug safety

Journal of neurology

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Saeed Shakibfar, Kristine Højgaard Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven, Maurizio Sessa
Drug Repurposing in Crohn's Disease Using Danish Real-World Data. Pragmatic and observational research 15 (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Saeed Shakibfar, Kristine Højgaard Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven, Maurizio Sessa
Drug Repurposing in Crohn's Disease Using Danish Real-World Data. Pragmatic and observational research 15 (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Guojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, Maurizio Sessa
Ubrogepant and Rimegepant: Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Studies. Expert opinion on drug safety (2023)
Guojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, Maurizio Sessa
Ubrogepant and rimegepant: systematic review, meta-analysis, and meta-regression of clinical studies. Expert opinion on drug safety (2023)
Guojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, Maurizio Sessa
Ubrogepant and rimegepant: systematic review, meta-analysis, and meta-regression of clinical studies. Expert opinion on drug safety 22 (1) (2023)
Diva Amiri, Maurizio Sessa, Morten Andersen, Miriam Kolko
Persistence and adherence with Latanoprost: A Danish register-based cohort study in older patients with glaucoma. Acta ophthalmologica (2023)
Vera Battini, Carla Carnovale, Emilio Clementi, Maurizio Sessa
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System. Expert opinion on drug safety (2023)
Guojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, Maurizio Sessa
Ubrogepant and rimegepant: systematic review, meta-analysis, and meta-regression of clinical studies. Expert opinion on drug safety 22 (1) (2023)
Matteo Ravaioli, Giuliana Germinario, Gerti Dajti, Maurizio Sessa, Francesco Vasuri, Antonio Siniscalchi, Maria Cristina Morelli, Matteo Serenari, Massimo Del Gaudio, Chiara Zanfi, Federica Odaldi, Valentina Rosa Bertuzzo, Lorenzo Maroni, Andrea Laurenzi, Matteo Cescon
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22 (10) (2022)
David Liang, Maurizio Sessa
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance. Expert opinion on drug safety 21 (9) (2022)
Marianne Meaidi, Henrik Støvring, Klaus Rostgaard, Christian Torp-Pedersen, Kristian Hay Kragholm, Morten Andersen, Maurizio Sessa
Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources. European journal of clinical pharmacology 77 (12) (2021)
Lasse Hjort Kyneb Jakobsen, Torbjörn Callréus, Maurizio Sessa, Mats Jerkeman, Morten Andersen, Tarec Christoffer El-Galaly
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphoma. Pharmacoepidemiology and drug safety 30 (4) (2021)
Maurizio Sessa, Kristian Kragholm, Anders Hviid, Morten Andersen
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert opinion on drug safety 20 (11) (2021)
Laura Pazzagli, Morten Andersen, Maurizio Sessa
Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study. Pharmacoepidemiology and drug safety (2021)
Maurizio Sessa, Morten Andersen
New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Maurizio Sessa, Annamaria Mascolo, Kim Peder Dalhoff, Morten Andersen
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine. Expert opinion on drug safety 19 (3) (2020)
Lanfranco Pellesi, Roberto De Icco, Hassan Youssef Alawie, Morten Andersen, David Liang, Sarkhan Amirguliyev, Mohammad Al-Mahdi Al-Karagholi, Faisal Mohammad Amin, Maurizio Sessa
A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine. Expert opinion on drug safety 20 (4) (2020)
Hadia Hashimi, Morten Andersen, Maurizio Sessa
Predictors of quetiapine extended-release formulation add-on in older patients exposed to antidepressant drugs: A Danish register-based cohort study. International journal of geriatric psychiatry 35 (10) (2020)
Alexander Sebastian Hauser, Albert Jelke Kooistra, Eva Sverrisdóttir, Maurizio Sessa
Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance. Expert opinion on drug safety 19 (8) (2020)
Maurizio Sessa, Annamaria Mascolo, Daniel Bech Rasmussen, Kristian Kragholm, Magnus Thorsten Jensen, Liberata Sportiello, Concetta Rafaniello, Giuseppe Michele Tari, Claudia Pagliaro, Morten Andersen, Francesco Rossi, Annalisa Capuano
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. Scientific reports 9 (1) (2019)
Arcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, Omar Saleh, Maurizio Sessa, Cosimo De Nunzio, Andrea Tubaro, Linda Vignozzi, Mario Maggi, Sergio Serni, Kevin T McVary, Steven A Kaplan, Stavros Gravas, Christopher Chapple, Mauro Gacci
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. Journal of clinical medicine 8 (8) (2019)
Gianmartin Cito, Maria Elisabetta Coccia, Rossella Fucci, Rita Picone, Andrea Cocci, Maurizio Sessa, Francesco Sessa, Francesca Rizzello, Elisabetta Micelli, Michele Trotta, Laura Badolato, Riccardo Campi, Luciana Criscuoli, Sergio Serni, Marco Carini, Alessandro Natali
Hepatitis B Surface Antigen Seropositive Men in Serodiscordant Couples: Effects on the Assisted Reproductive Outcomes. The world journal of men's health 39 (1) (2019)
Maurizio Sessa, Annamaria Mascolo, Torbjörn Callréus, Annalisa Capuano, Francesco Rossi, Morten Andersen
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®. Scientific reports 9 (1) (2019)
Maurizio Sessa, Francesca Futura Bernardi, Andrea Vitale, Beniamino Schiavone, Giulia Gritti, Annamaria Mascolo, Michele Bertini, Cristina Scavone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system. Journal of clinical pharmacy and therapeutics 43 (6) (2018)
C Rafaniello, Maurizio Sessa, F F Bernardi, M Pozzi, S Cheli, D Cattaneo, S Baldelli, M Molteni, R Bernardini, F Rossi, E Clementi, C Bravaccio, S Radice, A Capuano
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. The pharmacogenomics journal 18 (3) (2017)
Maurizio Sessa, Annamaria Mascolo, Mikkel Porsborg Andersen, Giuseppe Rosano, Francesco Rossi, Annalisa Capuano, Christian Torp-Pedersen
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study. PloS one 11 (7) (2016)